• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes Indanes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes

Professional Introduction to 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde (CAS No. 575504-30-2)

7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde is a heterocyclic aldehyde that has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural properties and potential biological activities. This compound, identified by its CAS number 575504-30-2, belongs to the class of indene derivatives, which are known for their diverse applications in medicinal chemistry. The presence of both hydroxyl and aldehyde functional groups in its molecular structure makes it a versatile scaffold for further chemical modifications and biological evaluations.

The compound's molecular formula, C??H??O?, reflects its aromatic nature and the presence of oxygen-containing functional groups. The 7-hydroxy moiety and the 6-methyl substituent contribute to its complexation capabilities with various biological targets, making it an attractive candidate for drug discovery initiatives. In recent years, there has been a growing interest in indene derivatives due to their potential role in modulating enzyme activities and interacting with specific receptors in biological systems.

Recent studies have highlighted the significance of 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde in the development of novel therapeutic agents. Researchers have been exploring its pharmacological profile, particularly its interactions with enzymes such as cytochrome P450 and other metabolic pathways. The aldehyde group at the 4-position provides a reactive site for further derivatization, enabling the synthesis of analogs with enhanced binding affinity and selectivity.

In the context of modern drug design, this compound has been investigated for its potential applications in treating various diseases. For instance, preliminary in vitro studies suggest that derivatives of 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde may exhibit anti-inflammatory properties by inhibiting key pro-inflammatory cytokines. Additionally, its structural motif has been explored as a lead compound for developing agents targeting neurological disorders, where indene derivatives have shown promise in modulating neurotransmitter release and receptor activity.

The synthesis of 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde involves multi-step organic reactions that highlight the ingenuity of synthetic chemists in constructing complex molecular frameworks. The process typically begins with the formation of the indene core through cyclization reactions, followed by functional group interconversion to introduce the hydroxyl and aldehyde groups. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to achieve high yields and purity, ensuring that the final product meets pharmaceutical standards.

The compound's stability under various conditions is another critical aspect that has been thoroughly examined. Studies have demonstrated that 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde retains its structural integrity under controlled storage conditions, making it suitable for long-term research applications. Furthermore, its solubility profile has been optimized for formulation purposes, allowing for easy integration into drug delivery systems.

From a regulatory perspective, the handling and use of 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde adhere to stringent safety guidelines to ensure that researchers and industrial personnel operate in a safe environment. While it is not classified as a hazardous material under current regulations, proper laboratory practices must be followed to prevent any unintended exposure. This includes using appropriate personal protective equipment (PPE) and working within fume hoods or other controlled environments.

The future prospects of 7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde are vast and exciting. As computational chemistry advances, virtual screening methods are being employed to identify potential drug candidates more efficiently. This compound serves as a valuable starting point for de novo design or scaffold hopping strategies, where its core structure can be modified to improve pharmacokinetic properties or target specificity.

In conclusion,7-Hydroxy-6-methyl-2,3-dihydro-1h-indene-4-carbaldehyde (CAS No. 575504-30-2) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential therapeutic applications. Ongoing research continues to uncover new ways in which this compound can be utilized to develop innovative treatments for various diseases. Its versatility as a chemical scaffold ensures that it will remain a cornerstone in medicinal chemistry for years to come.

• 40731-98-4(4-Hydroxy-1-indanone)
• 22242-84-8(4-Hydroxy-7-methyl-1-indanon)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)